VJHemOnc is committed to improving our service to you

SOHO Italy 2020 | New insights in the biology of myeloproliferative neoplasms

VJHemOnc is committed to improving our service to you

Anna Rita Migliaccio

Anna Rita Migliaccio, PhD, University of Bologna, Bologna, Italy, discusses novel insights into the pathogenesis of myelofibrosis and the changes involved in the development of myeloproliferative neoplasms from benign forms of disease. Dr Migliaccio outlines the use of ruxolitinib, which improves symptoms of myelofibrosis but highlights the need for curative therapies, including treatments targeting TGF-beta and p-selectin which have shown in mouse models to have curative effects. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter